Ophthalmology · Cheektowaga, NY
NPI
1194915371
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3095 Harlem Rd
Cheektowaga, NY, 14225
Phone (716) 896-8831
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
914 services
Medicare patients, 2024
238
Average age 73
Drug cost, 2024
$1.2M
7,828 prescriptions
Company payments, 2025
$27K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ephraim S Atwal was code 92136 (ultrasound - nonspecific), 231 times for 158 patients. In total Ephraim S Atwal billed 914 services in 29 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92136 Ultrasound - Nonspecific | Office | 231 | 158 | $27.07 | $6,254 |
| 66984 Cataract Surgery | Facility | 217 | 131 | $403.03 | $87K |
| 92025 Test - Miscellaneous | Office | 111 | 109 | $21.06 | $2,338 |
| 92012 Ophthalmological E&M | Office | 103 | 91 | $58.94 | $6,070 |
| 92134 Computerized Ophthalmic Imaging | Office | 77 | 71 | $25.95 | $1,998 |
| 92014 Ophthalmological E&M | Office | 42 | 42 | $71.28 | $2,994 |
| 92004 Ophthalmological E&M | Office | 39 | 39 | $82.60 | $3,221 |
| 92002 Ophthalmological E&M | Office | 29 | 29 | $43.71 | $1,268 |
By year: 2022 $82K for 519 services; 2023 $99K for 672 services; 2024 $125K for 914 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ephraim S Atwal prescribed most often to Medicare patients was Latanoprost, with 1,737 prescriptions and refills. In total Ephraim S Atwal wrote 7,828 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,737 | 3,930 | 523 | $35K |
| Prednisolone Acetate Generic | 923 | 1,191 | 571 | $50K |
| Ketorolac Tromethamine Generic | 860 | 881 | 512 | $14K |
| Ciprofloxacin Hcl Generic | 821 | 831 | 517 | $10K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 460 | 1,108 | 139 | $15K |
| Timolol Maleate Generic | 446 | 1,076 | 133 | $13K |
| Lumigan Bimatoprost | 345 | 723 | 104 | $196K |
| Brimonidine Tartrate Generic | 330 | 774 | 99 | $46K |
| Acetazolamide Er Acetazolamide | 230 | 238 | 160 | $1,373 |
| Cyclosporine Generic | 176 | 445 | 82 | $111K |
| Restasis Cyclosporine | 173 | 371 | 67 | $226K |
| Travoprost Generic | 137 | 308 | 43 | $39K |
| Dorzolamide Hcl Generic | 129 | 264 | 37 | $3,419 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 113 | 254 | 36 | $39K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 112 | 165 | 32 | $57K |
Brand drugs: 3,284 claims; generic drugs: 4,544 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ephraim S Atwal $27K ($27K in general payments such as food, travel and fees) from 13 companies. The largest payer was Alcon Research LLC with $25K.
| Company | Payments | Amount |
|---|---|---|
| Alcon Research LLC ALC | 18 | $25K |
| Alcon Vision LLC ALC | 41 | $1,687 |
| Glaukos Corporation GKOS | 3 | $357 |
| RxSight Inc RXST | 2 | $99.63 |
| Abbvie Inc. ABBV | 2 | $50.31 |
| Harrow Eye, LLC | 2 | $45.86 |
| Carl Zeiss Meditec USA, Inc. | 1 | $39.06 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $37.13 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $29.25 |
| Dompe US, Inc. | 1 | $25.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.